Photodynamic Therapy Market Set for Rapid Growth, Estimated to Reach USD 3.2 billion by 2030 at 8% CAGR: MarkNtel Adviso

Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Photodynamic Therapy Market, The Global Photodynamic Therapy Market size was valued at around USD 2 billion in 2024 and is projected to reach USD 3.2 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8% during the forecast period, i.e., 2025-30. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight & sustainable materials, rising demand for luxury & customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Photodynamic Therapy Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

Forecast Period: 2025-2030
Market Size in 2024: USD 2 billion
CAGR (2025-2030): 8%

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/photodynamic-therapy-market.html

Global Photodynamic Therapy Market Segmentation Breakdown:

By Product Type
- Photosensitizer Drugs - Market Size & Forecast 2020-2030F, USD Million
  - Porphyrin Derivatives – Market Size & Forecast 2020-2030F, USD Million
    - Hematoporphyrin Derivatives – Market Size & Forecast 2020-2030F, USD Million
    - Benzoporphyrin Acid – Market Size & Forecast 2020-2030F, USD Million
    - Texaphyrins – Market Size & Forecast 2020-2030F, USD Million
  - Aminolevulinic acid – Market Size & Forecast 2020-2030F, USD Million
  - Chlorins – Market Size & Forecast 2020-2030F, USD Million
  - Others – Market Size & Forecast 2020-2030F, USD Million
- Photodynamic Therapy Devices - Market Size & Forecast 2020-2030F, USD Million
  - Disposable Fiberoptics Light Delivery Device – Market Size & Forecast 2020-2030F, USD Million
  - Diode Laser – Market Size & Forecast 2020-2030F, USD Million
  - Lamp – Market Size & Forecast 2020-2030F, USD Million

60% of the Global Photodynamic Therapy Market is captured by the Photosensitizer Drugs segment, particularly porphyrin derivatives.

By Application
- Cancer- Market Size & Forecast 2020-2030F, USD Million
- Actinic Keratosis- Market Size & Forecast 2020-2030F, USD Million
- Acne- Market Size & Forecast 2020-2030F, USD Million
- Psoriasis- Market Size & Forecast 2020-2030F, USD Million
- Others- Market Size & Forecast 2020-2030F, USD Million

The cancer segment currently holds around 60% of the Global Photodynamic Therapy Market. The prevalence of PDT in the treatment of various cancers including esophageal cancer, non-small cell lung cancer, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) is the reason for its dominance.

By End User
- Hospitals- Market Size & Forecast 2020-2030F, USD Million
- Clinics and Dermatology Center- Market Size & Forecast 2020-2030F, USD Million
- Others- Market Size & Forecast 2020-2030F, USD Million

Geographical Growth Insights:

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

North America accounts for nearly 30% of the Global Photodynamic Therapy Market largely due to its superior clinical technology adoption, high healthcare spending, and well-established healthcare infrastructure.

MarkNtel Advisors Highlights Key Market Drivers for Photodynamic Therapy Market:

Rising Prevalence of Cancer & Skin Diseases – The Global Photodynamic Remedy (PDT) Market is fueled by the growing prevalence of skin cancers and other malignancies. Skin cancers, specifically basal cellular carcinoma (BCC) and squamous cellular carcinoma (SCC) are some of the most common cancers globally. As per the World Health Organization (WHO), approximately 2-3 million non-melanoma skin cancers and 132,000 melanoma cases are recognized annually. As the prevalence of these skin cancers increases, the demand for effective, minimally invasive treatments like PDT is growing. Moreover, in regions like North America and Europe, populations are more prone to various skin problems and skin cancer. According to the American Cancer Society, approximately 97,610 new instances of MSC had been diagnosed nationwide in 2023. Also in Europe Overall, 150,627 people were diagnosed with Melanoma skin cancer (MSC) in 2020.

In addition to its oncology programs, PDT is being explored for less non-cancerous indications, which include actinic keratosis, pimples, and age-associated macular degeneration. PDT remedies offer patients fewer side effects, quicker recovery times, and reduced healthcare prices in assessment to conventional remedies like surgical processes, radiation, or chemotherapy. This convergence of factors positions PDT as a key participant in the evolving cancer treatment landscape.

A Comprehensive Analysis of Leading Companies in Global Photodynamic Therapy Market

Biofronterra AG, Lumibird, Sun Pharmaceutical Industries Ltd., Galderma, Advanz Pharma, Rakuten Medical, Nanospectra Biosciences, Theralase Technologies Inc., Modulight Corporation, Novartis AG, Luzitin S.A, Steba Biotech, Biolitec Pharma, Photoatomic and Others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/photodynamic-therapy-market.html

Global Photodynamic Therapy Industry Recent Development:

June 2024: Biofrontera AG launched the RhodeXL lamp with Ameluz (aminolevulinic acid hydrochloride) topical gel for patients suffering from actinic keratosis to strengthen their product portfolio.
February 2023: Galderma collaborated with German Medical Engineering (GME) to promote their photosensitizer drug, Metvix. This helped the company to strengthen its brand presence globally.

What are the growth Opportunity driving the Global Photodynamic Therapy Market?

Expansion into Dermatology & Cosmetic Applications – The most significant opportunities lie in its growth in dermatology and cosmetic applications. PDT is being followed for cosmetic dermatology and skin rejuvenation due to its non-invasive nature and potential to pinpoint specific skin situations efficiently. In dermatology, PDT is gaining a reputation for treating actinic keratosis (AK), a precancerous pores and skin condition that impacts lots of human beings globally. In a study, it is estimated that more than 58 million human beings in the U.S. have some shape of actinic keratosis, which could bring about skin cancers if left untreated. PDT is likewise being used for acne treatments, particularly in times wherein different treatments were useless.

Moreover, PDT’s cosmetic advantages include prolonged skin rejuvenation, and reduced symptoms of growing old, inclusive of wrinkles and solar damage. This broadening of PDT's indications gives tremendous market capacity, as patients are searching for less invasive options to conventional dermatological treatments.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.

Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.

Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/photodynamic-therapy-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

The Global Organ-on-Chip Marketsize was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30).
The Global ESG Reporting Software Marketsize was valued at around USD 0.95 billion in 2024 and is projected to reach USD 2.6 billion by 2030. Along with this, the market is estimated to grow at a CAGR of 18% during the forecast period, i.e., 2025-30.
The Global Mushroom Market size was valued at around USD 64 billionin 2024 and is projected to reach USD 99 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8% during the forecast period, i.e., 2025-30.